Metoprolol Succinate Tablet, Extended Release
NDC Package 60760-993-90
Package Information
Metoprolol Succinate tablets is a medication a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. This formulation utilizes a tablet, extended release delivery system. Marketed by St. Mary's Medical Park Pharmacy, this product is identified by NDC 60760-993 and is authorized under FDA application ANDA213854.
Identification & Billing
- RxCUI: 866436 - metoprolol succinate 50 MG 24HR Extended Release Oral Tablet
- RxCUI: 866436 - 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet
- RxCUI: 866436 - 24 HR metoprolol succinate 50 MG (as metoprolol succinate 47.5 MG equivalent to 50 MG metoprolol tartrate) Extended Release Oral Tablet
- RxCUI: 866436 - metoprolol succinate 50 MG 24 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60760 - St. Mary's Medical Park Pharmacy
- 60760-993 - Metoprolol Succinate
- 60760-993-90 - 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
- 60760-993 - Metoprolol Succinate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60760-993-90 identifies a specific commercial package of 90 tablet, extended release in 1 bottle, plastic of Metoprolol Succinate, a human prescription drug labeled by St. Mary's Medical Park Pharmacy. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This tablet, extended release is formulated for oral use and contains metoprolol succinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by St. Mary's Medical Park Pharmacy on October 15, 2025. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.
How is this St. Mary's Medical Park Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60760099390. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.